Sinopharm
1099.HK
#2152
Rank
C$9.74 B
Marketcap
$3.12
Share price
-2.02%
Change (1 day)
-17.45%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Earnings for Sinopharm (1099.HK)

Earnings in 2023 (TTM): C$3.25 Billion

According to Sinopharm's latest financial reports the company's current earnings are C$84.39 Billion. a decrease over its 2022 earnings that were of C$4.43 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Sinopharm from 2006 to 2023

Annual earnings

Year Earnings Change
2023 C$4.40 B-0.73%
2022 C$4.43 B-1.72%
2021C$4.51 B11.7%
2020C$4.03 B18.44%
2019C$3.40 B10.85%
2018C$3.07 B3.05%
2017C$2.98 B36.48%
2016C$2.18 B7.11%
2015C$2.04 B12.38%
2014C$1.81 B25.05%
2013C$1.45 B22.54%
2012C$1.18 B35.43%
2011C$0.87 B52.24%
2010C$0.57 B30.99%
2009C$0.43 B60.59%
2008C$0.27 B48.29%
2007C$0.18 B123.29%
2006C$82.55 M